Creso Pharma and Red Light Holland have entered into a definitive merger agreement to create The HighBrid Lab, a global psychedelics and cannabinoid company with an implied pro forma equity value of A$371 million.
Canopy Growth founder Bruce Linton is expected to join as non-executive chairman.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.